Loading...

Welcome to the Regeneron COVID-19 Dashboard

This dashboard contains aggregated information on SARS-CoV-2 (hCoV-19) genomes and associated patient metadata, gathered in partnership with the GISAID initiative.

The goal of the dashboard is to enable scientists to understand the evolution of this emerging coronavirus by monitoring and displaying pertinent information. For example, the dashboard displays the novel mutations in SARS-CoV-2 (hCoV-19) genomes across time and geographical location, which facilitates the identification of a mutation that may increase transmission or virulence.

In addition, there is de-identified patient demographic information such as country of origin, patient status, and age, which provides further insights into the populations most susceptible to the virus.

2,584,990

SARS-CoV-2 (hCoV-19) genomes


August 03, 2021

02:25 AM ET

Last data update


Top Lineages Per Country (Past 12 Weeks)

Loading...

Top* Lineages (Past 12 Weeks)

Lineage Country Percent Lineage Count Total Count
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Estonia 100% 79 79
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
United Kingdom 95% 154,617 162,490
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Russia 92% 1,170 1,270
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Lithuania 81% 830 1,019
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Slovakia 81% 734 902
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Slovenia 78% 909 1,165
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Malta 78% 62 80
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Portugal 77% 2,991 3,885
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Finland 75% 997 1,338
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Poland 71% 710 997
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Denmark 64% 14,776 23,160
B.1.1.318B.1.1.318 Mutations
ProteinMutations
Spike (RBD)E484K
Spike (non-RBD)D614G, D796H, P681H, T95I, Y144-
Greece 63% 161 256
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Norway 61% 1,098 1,809
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Romania 61% 103 170
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Bulgaria 60% 198 330
AY.3AY.3 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (79%), F157- (79%), P681R, R158- (79%), T19R
Austria 59% 1,117 1,900
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Switzerland 55% 1,930 3,481
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Netherlands 53% 4,314 8,118
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Croatia 53% 359 677
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Italy 52% 4,185 8,110
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Belgium 51% 3,043 5,990
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Sweden 50% 4,657 9,238
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Czechia 50% 366 734
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Ireland 50% 2,324 4,686
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Sweden 48% 4,411 9,238
P.1P.1 Mutations
ProteinMutations
Spike (RBD)E484K, K417T, N501Y
Spike (non-RBD)D138Y, D614G, H655Y, L18F, P26S, R190S, T20N, T1027I, V1176F
Luxembourg 48% 817 1,720
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Germany 46% 5,686 12,232
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Croatia 46% 311 677
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Germany 46% 5,602 12,232
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Czechia 44% 325 734
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Netherlands 44% 3,592 8,118
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
France 44% 3,884 8,924
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Spain 43% 4,109 9,515
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Bosnia and Herzegovina 43% 27 63
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Ireland 42% 1,988 4,686
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Spain 41% 3,857 9,515
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Luxembourg 40% 693 1,720
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Belgium 40% 2,402 5,990
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Bosnia and Herzegovina 40% 25 63
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Switzerland 38% 1,324 3,481
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Norway 37% 675 1,809
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Bulgaria 37% 121 330
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Romania 36% 62 170
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Denmark 35% 8,207 23,160
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
France 34% 3,052 8,924
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Greece 32% 83 256
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Turkey 32% 496 1,544
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Italy 29% 2,353 8,110
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Austria 27% 510 1,900
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Portugal 20% 762 3,885
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Poland 19% 193 997
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Finland 18% 247 1,338
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Slovakia 18% 158 902
AY.3AY.3 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (79%), F157- (79%), P681R, R158- (79%), T19R
Turkey 17% 270 1,544
B.1B.1 Mutations
ProteinMutations
Spike (non-RBD)D614G
Turkey 17% 259 1,544
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Malta 12% 10 80
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Lithuania 12% 119 1,019
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Slovenia 12% 135 1,165
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Austria 11% 215 1,900
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Luxembourg 10% 178 1,720
*Criteria: Above 10%, minimum of 50 samples per country.
Lineage Country Percent Lineage Count Total Count
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Martinique 96% 54 56
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Sint Maarten 88% 173 196
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
United States 49% 26,115 53,290
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Canada 46% 3,515 7,634
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Canada 41% 3,117 7,634
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Puerto Rico 41% 80 196
P.1P.1 Mutations
ProteinMutations
Spike (RBD)E484K, K417T, N501Y
Spike (non-RBD)D138Y, D614G, H655Y, L18F, P26S, R190S, T20N, T1027I, V1176F
Costa Rica 38% 30 80
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Mexico 35% 1,947 5,603
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
United States 26% 13,730 53,290
P.1P.1 Mutations
ProteinMutations
Spike (RBD)E484K, K417T, N501Y
Spike (non-RBD)D138Y, D614G, H655Y, L18F, P26S, R190S, T20N, T1027I, V1176F
Mexico 26% 1,431 5,603
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Puerto Rico 19% 38 196
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Costa Rica 19% 15 80
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Costa Rica 15% 12 80
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Mexico 13% 723 5,603
P.1P.1 Mutations
ProteinMutations
Spike (RBD)E484K, K417T, N501Y
Spike (non-RBD)D138Y, D614G, H655Y, L18F, P26S, R190S, T20N, T1027I, V1176F
Puerto Rico 13% 25 196
AY.3AY.3 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (79%), F157- (79%), P681R, R158- (79%), T19R
Puerto Rico 13% 25 196
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Sint Maarten 11% 21 196
B.1.1.519B.1.1.519 Mutations
ProteinMutations
Spike (RBD)T478K
Spike (non-RBD)D614G, P681H, T732A
Mexico 11% 593 5,603
*Criteria: Above 10%, minimum of 50 samples per country.
Lineage Country Percent Lineage Count Total Count
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Singapore 98% 1,352 1,383
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
China 92% 58 63
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
India 91% 2,692 2,958
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Nepal 89% 66 74
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Hong Kong 86% 102 119
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Israel 84% 1,678 1,988
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Kuwait 84% 115 137
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Indonesia 82% 985 1,205
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Japan 76% 1,834 2,415
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Sri Lanka 75% 227 303
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Bangladesh 71% 146 206
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Qatar 70% 40 57
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Malaysia 67% 66 98
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Cambodia 64% 208 325
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Thailand 56% 78 139
B.1.619.1B.1.619.1 Mutations
ProteinMutations
Spike (RBD)E484K, N440K
Spike (non-RBD)D614G, D936N, I210T, S939F, T1027I
South Korea 50% 776 1,563
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Thailand 43% 60 139
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
South Korea 29% 459 1,563
AY.3AY.3 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (79%), F157- (79%), P681R, R158- (79%), T19R
Cambodia 24% 79 325
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Japan 21% 496 2,415
B.1.351B.1.351 Mutations
ProteinMutations
Spike (RBD)E484K (87%), K417N, N501Y (87%)
Spike (non-RBD)A243- (58%), A701V, D80A, D215G, D614G, L242- (59%), L244- (54%)
Malaysia 20% 20 98
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Sri Lanka 19% 57 303
AY.3AY.3 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (79%), F157- (79%), P681R, R158- (79%), T19R
Bangladesh 18% 38 206
B.1.351B.1.351 Mutations
ProteinMutations
Spike (RBD)E484K (87%), K417N, N501Y (87%)
Spike (non-RBD)A243- (58%), A701V, D80A, D215G, D614G, L242- (59%), L244- (54%)
Qatar 18% 10 57
B.1.466.2B.1.466.2 Mutations
ProteinMutations
Spike (RBD)N439K
Spike (non-RBD)D614G, P681R
Indonesia 11% 136 1,205
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
South Korea 11% 165 1,563
*Criteria: Above 10%, minimum of 50 samples per country.
Lineage Country Percent Lineage Count Total Count
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Australia 91% 1,498 1,652
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
New Zealand 84% 76 91
*Criteria: Above 10%, minimum of 50 samples per country.
Lineage Country Percent Lineage Count Total Count
P.1P.1 Mutations
ProteinMutations
Spike (RBD)E484K, K417T, N501Y
Spike (non-RBD)D138Y, D614G, H655Y, L18F, P26S, R190S, T20N, T1027I, V1176F
French Guiana 92% 81 88
C.37C.37 Mutations
ProteinMutations
Spike (RBD)F490S, L452Q
Spike (non-RBD)D253N (85%), D614G, G75V, G252- (86%), L249- (86%), P251- (86%), R246- (85%), S247- (85%), T76I, T250- (86%), T859N, Y248- (86%)
Peru 83% 77 93
P.1P.1 Mutations
ProteinMutations
Spike (RBD)E484K, K417T, N501Y
Spike (non-RBD)D138Y, D614G, H655Y, L18F, P26S, R190S, T20N, T1027I, V1176F
Brazil 74% 1,997 2,688
P.1P.1 Mutations
ProteinMutations
Spike (RBD)E484K, K417T, N501Y
Spike (non-RBD)D138Y, D614G, H655Y, L18F, P26S, R190S, T20N, T1027I, V1176F
Chile 70% 1,298 1,845
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Curacao 55% 32 58
P.1P.1 Mutations
ProteinMutations
Spike (RBD)E484K, K417T, N501Y
Spike (non-RBD)D138Y, D614G, H655Y, L18F, P26S, R190S, T20N, T1027I, V1176F
Aruba 31% 59 188
B.1.621B.1.621 Mutations
ProteinMutations
Spike (RBD)E484K, N501Y, R346K
Spike (non-RBD)D614G, D950N, P681H, T95I, Y144T (77%), Y145S (78%), ins145N (78%)
Aruba 26% 48 188
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Aruba 26% 48 188
B.1.526B.1.526 Mutations
ProteinMutations
Spike (non-RBD)D253G (65%), D614G, L5F (64%), T95I (66%)
Ecuador 25% 179 718
C.37C.37 Mutations
ProteinMutations
Spike (RBD)F490S, L452Q
Spike (non-RBD)D253N (85%), D614G, G75V, G252- (86%), L249- (86%), P251- (86%), R246- (85%), S247- (85%), T76I, T250- (86%), T859N, Y248- (86%)
Chile 22% 412 1,845
C.37C.37 Mutations
ProteinMutations
Spike (RBD)F490S, L452Q
Spike (non-RBD)D253N (85%), D614G, G75V, G252- (86%), L249- (86%), P251- (86%), R246- (85%), S247- (85%), T76I, T250- (86%), T859N, Y248- (86%)
Ecuador 17% 120 718
P.1P.1 Mutations
ProteinMutations
Spike (RBD)E484K, K417T, N501Y
Spike (non-RBD)D138Y, D614G, H655Y, L18F, P26S, R190S, T20N, T1027I, V1176F
Ecuador 16% 112 718
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Curacao 16% 9 58
B.1.621B.1.621 Mutations
ProteinMutations
Spike (RBD)E484K, N501Y, R346K
Spike (non-RBD)D614G, D950N, P681H, T95I, Y144T (77%), Y145S (78%), ins145N (78%)
Ecuador 14% 102 718
P.1P.1 Mutations
ProteinMutations
Spike (RBD)E484K, K417T, N501Y
Spike (non-RBD)D138Y, D614G, H655Y, L18F, P26S, R190S, T20N, T1027I, V1176F
Curacao 14% 8 58
*Criteria: Above 10%, minimum of 50 samples per country.
Lineage Country Percent Lineage Count Total Count
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Gambia 99% 74 75
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Uganda 95% 126 132
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Rwanda 77% 97 126
B.1.351.2B.1.351.2 Mutations
ProteinMutations
Spike (RBD)E484K, K417N, N501Y
Spike (non-RBD)A243-, A701V, D80A, D215G, D614G, L18F, L242-, L244-
Reunion 63% 182 288
AY.3AY.3 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (79%), F157- (79%), P681R, R158- (79%), T19R
Kenya 60% 262 438
B.1.351.2B.1.351.2 Mutations
ProteinMutations
Spike (RBD)E484K, K417N, N501Y
Spike (non-RBD)A243-, A701V, D80A, D215G, D614G, L18F, L242-, L244-
France (Réunion Island) 59% 299 511
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Botswana 55% 228 416
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
South Africa 39% 975 2,479
B.1.620B.1.620 Mutations
ProteinMutations
Spike (RBD)E484K, S477N
Spike (non-RBD)A243-, D614G, D1118H, H69-, H245Y, L242- (90%), L244-, P26S, P681H, T1027I, V70-, V126A, Y144-
Republic of Congo 38% 21 55
B.1.351B.1.351 Mutations
ProteinMutations
Spike (RBD)E484K (87%), K417N, N501Y (87%)
Spike (non-RBD)A243- (58%), A701V, D80A, D215G, D614G, L242- (59%), L244- (54%)
Reunion 36% 105 288
B.1.351B.1.351 Mutations
ProteinMutations
Spike (RBD)E484K (87%), K417N, N501Y (87%)
Spike (non-RBD)A243- (58%), A701V, D80A, D215G, D614G, L242- (59%), L244- (54%)
France (Réunion Island) 36% 184 511
B.1.351B.1.351 Mutations
ProteinMutations
Spike (RBD)E484K (87%), K417N, N501Y (87%)
Spike (non-RBD)A243- (58%), A701V, D80A, D215G, D614G, L242- (59%), L244- (54%)
Botswana 33% 139 416
AY.3AY.3 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (79%), F157- (79%), P681R, R158- (79%), T19R
South Africa 32% 787 2,479
P.1.7P.1.7 Mutations
ProteinMutations
Spike (RBD)E484K, K417T, N501Y
Spike (non-RBD)D138Y, D614G, H655Y, L18F, P26S, P681H, R190S, T20N, T1027I, V1176F
Republic of Congo 31% 17 55
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Kenya 26% 114 438
B.1.351B.1.351 Mutations
ProteinMutations
Spike (RBD)E484K (87%), K417N, N501Y (87%)
Spike (non-RBD)A243- (58%), A701V, D80A, D215G, D614G, L242- (59%), L244- (54%)
South Africa 18% 440 2,479
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Republic of Congo 15% 8 55
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Kenya 12% 53 438
B.1.351B.1.351 Mutations
ProteinMutations
Spike (RBD)E484K (87%), K417N, N501Y (87%)
Spike (non-RBD)A243- (58%), A701V, D80A, D215G, D614G, L242- (59%), L244- (54%)
Rwanda 11% 14 126
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Republic of Congo 11% 6 55
*Criteria: Above 10%, minimum of 50 samples per country.
Lineage State Percent Lineage Count Total Count
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Vermont 79% 87 110
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Nevada 78% 2,267 2,911
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Massachusetts 75% 1,448 1,919
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Utah 72% 1,618 2,248
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
South Dakota 68% 28 41
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Arkansas 68% 586 862
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Kansas 64% 1,155 1,805
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
West Virginia 63% 137 217
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Wyoming 62% 530 857
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
New Jersey 62% 821 1,332
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Colorado 60% 1,301 2,156
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
North Dakota 60% 134 224
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Alaska 58% 414 715
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Kentucky 58% 118 204
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
District of Columbia 54% 56 103
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
California 53% 3,446 6,484
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Delaware 53% 54 102
AY.3.1AY.3.1 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (83%), F157- (83%), P681R, R158- (83%), T19R
Mississippi 52% 357 684
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Louisiana 52% 592 1,141
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Oklahoma 52% 62 120
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Wisconsin 52% 289 560
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Missouri 51% 916 1,786
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Indiana 51% 435 850
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Montana 51% 214 422
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Alabama 51% 181 357
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Iowa 51% 40 79
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
New Mexico 50% 309 614
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Nebraska 50% 289 576
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Pennsylvania 50% 177 353
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Tennessee 50% 123 246
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
North Carolina 50% 635 1,274
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Texas 50% 1,663 3,359
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Arizona 49% 589 1,214
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
New York 48% 645 1,331
B.1.526B.1.526 Mutations
ProteinMutations
Spike (non-RBD)D253G (65%), D614G, L5F (64%), T95I (66%)
Maine 48% 142 294
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
South Carolina 48% 157 329
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Connecticut 47% 162 346
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Michigan 46% 88 191
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Ohio 45% 355 783
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Oregon 43% 336 777
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Minnesota 43% 455 1,055
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Georgia 43% 289 671
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Maryland 43% 353 827
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Florida 41% 1,534 3,744
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Virginia 41% 306 753
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Idaho 40% 155 384
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Illinois 39% 450 1,141
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
New Hampshire 37% 32 87
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Rhode Island 34% 70 205
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Hawaii 32% 118 370
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Washington 30% 1,199 4,041
*Criteria: Minimum of 20 samples per state.

Top Emerging* Lineages (Past 12 Weeks)

Lineage Country 2-Week Period Change Previous Support Current Support
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Slovenia 2021-06-28 6% -> 68% (+62%) 24 / 378 107 / 157
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Denmark 2021-06-28 20% -> 79% (+59%) 397 / 1,940 3,774 / 4,771
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Lithuania 2021-06-28 10% -> 61% (+51%) 22 / 210 89 / 145
P.1P.1 Mutations
ProteinMutations
Spike (RBD)E484K, K417T, N501Y
Spike (non-RBD)D138Y, D614G, H655Y, L18F, P26S, R190S, T20N, T1027I, V1176F
Luxembourg 2021-06-28 14% -> 65% (+51%) 18 / 129 611 / 944
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Switzerland 2021-06-28 27% -> 76% (+49%) 128 / 473 552 / 722
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Finland 2021-06-14 29% -> 79% (+49%) 84 / 285 399 / 506
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Netherlands 2021-06-28 36% -> 81% (+45%) 606 / 1,662 2,406 / 2,961
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Slovakia 2021-07-12 45% -> 89% (+43%) 65 / 143 63 / 71
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Ireland 2021-06-28 39% -> 82% (+43%) 606 / 1,553 1,323 / 1,618
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Turkey 2021-06-28 27% -> 66% (+38%) 277 / 1,011 173 / 263
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Romania 2021-06-14 12% -> 50% (+38%) 9 / 75 23 / 46
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Croatia 2021-06-14 24% -> 60% (+37%) 74 / 313 82 / 136
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Belgium 2021-06-28 36% -> 72% (+36%) 347 / 963 1,120 / 1,555
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Poland 2021-07-12 44% -> 79% (+35%) 76 / 173 69 / 87
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
France 2021-06-14 12% -> 47% (+35%) 249 / 2,077 701 / 1,483
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Spain 2021-07-12 60% -> 95% (+35%) 1,933 / 3,220 710 / 747
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Norway 2021-06-28 25% -> 59% (+34%) 132 / 525 325 / 547
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Germany 2021-06-14 13% -> 47% (+34%) 700 / 5,283 1,151 / 2,429
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Bulgaria 2021-06-14 7% -> 41% (+34%) 7 / 103 51 / 125
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Czechia 2021-06-28 42% -> 75% (+34%) 62 / 149 166 / 220
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Italy 2021-06-28 30% -> 62% (+32%) 513 / 1,691 1,597 / 2,572
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Portugal 2021-06-14 51% -> 82% (+31%) 639 / 1,242 952 / 1,157
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Sweden 2021-06-28 40% -> 68% (+29%) 1,064 / 2,692 1,273 / 1,859
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Greece 2021-06-14 27% -> 45% (+18%) 47 / 176 36 / 80
AY.3AY.3 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (79%), F157- (79%), P681R, R158- (79%), T19R
Austria 2021-06-28 51% -> 69% (+18%) 360 / 708 336 / 489
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
United Kingdom 2021-06-14 88% -> 96% (+7%) 33,155 / 37,644 41,237 / 43,156
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Russia 2021-06-14 89% -> 94% (+5%) 691 / 776 174 / 185
*Criteria: >= +5% or >= 2x fold change between 2 week periods with >= 20 samples.
Lineage Country 2-Week Period Change Previous Support Current Support
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Canada 2021-06-28 25% -> 80% (+55%) 456 / 1,853 633 / 795
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Puerto Rico 2021-06-14 4% -> 39% (+35%) 2 / 51 22 / 56
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Mexico 2021-06-28 32% -> 63% (+30%) 582 / 1,803 727 / 1,162
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Sint Maarten 2021-07-12 13% -> 42% (+29%) 5 / 39 16 / 38
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
United States 2021-06-14 20% -> 45% (+25%) 2,862 / 14,523 6,703 / 14,952
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Costa Rica 2021-06-28 15% -> 38% (+23%) 4 / 27 8 / 21
*Criteria: >= +5% or >= 2x fold change between 2 week periods with >= 20 samples.
Lineage Country 2-Week Period Change Previous Support Current Support
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Hong Kong 2021-06-14 50% -> 100% (+50%) 15 / 30 52 / 52
AY.3AY.3 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (79%), F157- (79%), P681R, R158- (79%), T19R
Cambodia 2021-07-12 6% -> 46% (+40%) 5 / 81 40 / 87
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Bangladesh 2021-06-28 59% -> 93% (+34%) 48 / 82 65 / 70
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Japan 2021-06-28 21% -> 53% (+32%) 100 / 478 181 / 339
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Israel 2021-06-14 56% -> 88% (+32%) 24 / 43 701 / 796
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Thailand 2021-07-12 66% -> 96% (+31%) 21 / 32 27 / 28
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Sri Lanka 2021-06-28 9% -> 39% (+31%) 12 / 140 24 / 61
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
South Korea 2021-06-14 2% -> 28% (+26%) 8 / 434 152 / 544
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Kuwait 2021-06-14 56% -> 81% (+25%) 15 / 27 34 / 42
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Indonesia 2021-06-14 67% -> 88% (+22%) 241 / 362 579 / 655
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Malaysia 2021-06-14 55% -> 72% (+17%) 21 / 38 36 / 50
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
India 2021-07-12 88% -> 96% (+9%) 183 / 209 25 / 26
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Nepal 2021-06-28 85% -> 90% (+6%) 33 / 39 19 / 21
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Singapore 2021-07-12 94% -> 100% (+6%) 95 / 101 819 / 820
*Criteria: >= +5% or >= 2x fold change between 2 week periods with >= 20 samples.
Lineage Country 2-Week Period Change Previous Support Current Support
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Australia 2021-06-14 42% -> 83% (+41%) 48 / 115 192 / 231
*Criteria: >= +5% or >= 2x fold change between 2 week periods with >= 20 samples.
Lineage Country 2-Week Period Change Previous Support Current Support
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Aruba 2021-07-12 29% -> 75% (+45%) 7 / 24 41 / 55
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Brazil 2021-07-12 10% -> 21% (+11%) 72 / 720 12 / 57
P.1P.1 Mutations
ProteinMutations
Spike (RBD)E484K, K417T, N501Y
Spike (non-RBD)D138Y, D614G, H655Y, L18F, P26S, R190S, T20N, T1027I, V1176F
Ecuador 2021-06-28 10% -> 20% (+10%) 15 / 144 64 / 318
P.1P.1 Mutations
ProteinMutations
Spike (RBD)E484K, K417T, N501Y
Spike (non-RBD)D138Y, D614G, H655Y, L18F, P26S, R190S, T20N, T1027I, V1176F
Chile 2021-06-14 66% -> 72% (+6%) 349 / 525 394 / 545
*Criteria: >= +5% or >= 2x fold change between 2 week periods with >= 20 samples.
Lineage Country 2-Week Period Change Previous Support Current Support
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Botswana 2021-06-14 13% -> 66% (+53%) 13 / 101 130 / 196
AY.3AY.3 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (79%), F157- (79%), P681R, R158- (79%), T19R
South Africa 2021-07-12 28% -> 75% (+47%) 169 / 607 62 / 83
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
France (Réunion Island) 2021-07-12 1% -> 43% (+43%) 1 / 158 23 / 53
AY.3AY.3 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (79%), F157- (79%), P681R, R158- (79%), T19R
Kenya 2021-06-14 22% -> 53% (+31%) 20 / 91 49 / 92
B.1.351B.1.351 Mutations
ProteinMutations
Spike (RBD)E484K (87%), K417N, N501Y (87%)
Spike (non-RBD)A243- (58%), A701V, D80A, D215G, D614G, L242- (59%), L244- (54%)
Reunion 2021-06-14 28% -> 36% (+8%) 21 / 76 27 / 76
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Rwanda 2021-06-28 75% -> 83% (+7%) 70 / 93 24 / 29
*Criteria: >= +5% or >= 2x fold change between 2 week periods with >= 20 samples.
Lineage State 2-Week Period Change Previous Support Current Support
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
District of Columbia 2021-06-28 10% -> 66% (+55%) 3 / 29 19 / 29
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Idaho 2021-06-28 13% -> 64% (+51%) 9 / 70 51 / 80
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Michigan 2021-06-28 15% -> 64% (+49%) 7 / 46 45 / 70
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
South Carolina 2021-06-28 28% -> 75% (+47%) 25 / 89 95 / 126
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Alaska 2021-06-28 29% -> 73% (+44%) 46 / 157 183 / 251
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Louisiana 2021-06-28 19% -> 63% (+43%) 23 / 118 208 / 332
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Pennsylvania 2021-06-28 15% -> 57% (+42%) 17 / 113 45 / 79
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Ohio 2021-06-28 24% -> 65% (+41%) 36 / 152 147 / 227
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Florida 2021-06-28 34% -> 74% (+40%) 460 / 1,356 874 / 1,186
AY.3AY.3 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (79%), F157- (79%), P681R, R158- (79%), T19R
Washington 2021-07-12 39% -> 78% (+39%) 417 / 1,056 406 / 520
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Minnesota 2021-06-14 7% -> 45% (+38%) 26 / 369 139 / 310
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
North Carolina 2021-06-14 6% -> 43% (+37%) 15 / 234 170 / 394
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Kentucky 2021-06-28 20% -> 57% (+37%) 16 / 80 26 / 46
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Oregon 2021-07-12 35% -> 71% (+36%) 63 / 181 79 / 111
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Indiana 2021-06-14 20% -> 56% (+36%) 55 / 273 105 / 187
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Arkansas 2021-06-14 24% -> 60% (+36%) 26 / 108 95 / 159
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Wyoming 2021-06-14 25% -> 61% (+36%) 65 / 258 135 / 222
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Alabama 2021-06-28 39% -> 75% (+36%) 33 / 84 125 / 167
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
New Mexico 2021-06-28 22% -> 57% (+35%) 42 / 190 92 / 160
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Arizona 2021-06-14 14% -> 48% (+34%) 40 / 284 220 / 454
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Virginia 2021-06-28 28% -> 62% (+34%) 55 / 193 190 / 306
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Georgia 2021-06-28 32% -> 66% (+34%) 61 / 189 183 / 278
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Rhode Island 2021-06-28 30% -> 64% (+33%) 14 / 46 28 / 44
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Massachusetts 2021-06-28 42% -> 75% (+33%) 40 / 95 145 / 193
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
New Jersey 2021-06-14 29% -> 61% (+31%) 95 / 327 247 / 408
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Colorado 2021-06-14 40% -> 71% (+31%) 428 / 1,068 333 / 466
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
North Dakota 2021-06-28 22% -> 54% (+31%) 9 / 40 14 / 26
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Montana 2021-07-12 51% -> 82% (+31%) 47 / 93 62 / 76
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Illinois 2021-06-28 33% -> 63% (+30%) 98 / 296 176 / 281
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Nevada 2021-06-14 41% -> 71% (+30%) 81 / 196 678 / 957
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Maryland 2021-06-28 29% -> 58% (+29%) 44 / 152 182 / 315
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
New York 2021-06-14 20% -> 48% (+28%) 91 / 461 140 / 293
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Iowa 2021-06-14 32% -> 60% (+28%) 8 / 25 15 / 25
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Connecticut 2021-06-14 12% -> 40% (+28%) 11 / 91 32 / 80
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Wisconsin 2021-06-28 44% -> 71% (+27%) 52 / 119 91 / 128
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
California 2021-06-14 21% -> 48% (+27%) 294 / 1,423 1,061 / 2,213
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Hawaii 2021-06-14 10% -> 36% (+26%) 17 / 167 52 / 145
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Texas 2021-06-28 44% -> 69% (+25%) 475 / 1,072 831 / 1,205
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Nebraska 2021-06-14 19% -> 43% (+24%) 11 / 59 47 / 110
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Tennessee 2021-06-14 12% -> 35% (+22%) 12 / 98 27 / 78
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Delaware 2021-06-14 49% -> 71% (+22%) 32 / 65 22 / 31
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Kansas 2021-06-14 35% -> 56% (+21%) 72 / 205 181 / 323
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Maine 2021-06-28 7% -> 26% (+19%) 5 / 70 10 / 38
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Utah 2021-06-14 61% -> 77% (+16%) 561 / 921 762 / 989
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
West Virginia 2021-06-14 1% -> 16% (+15%) 1 / 137 8 / 51
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Oklahoma 2021-06-28 52% -> 67% (+14%) 23 / 44 22 / 33
AY.3.1AY.3.1 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (83%), F157- (83%), P681R, R158- (83%), T19R
Mississippi 2021-06-14 41% -> 55% (+14%) 31 / 75 76 / 137
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Missouri 2021-06-14 41% -> 55% (+14%) 177 / 427 323 / 586
*Criteria: >= +5% or >= 2x fold change between 2-week periods with >= 20 samples.

Data Timeline

Loading...
Loading...

Dashboard Timeline

April 16, 2021
08:50PM

Dashboard UI/graphs updated

Added emerging lineages tracking and top lineages tracking per US state to home page
April 16, 2021
08:00PM

Dashboard backend pipeline overhauled

Overhauled backend pipeline to automatically download and QC data from GISAID daily
April 05, 2021
03:30PM

Dashboard UI/graphs updated

Added top and emerging lineage maps and graphs. Overhauled home page
March 23, 2021
06:00PM

Dashboard performance overhauled

Added caching and refactored all graphs for performance before public release
November 13, 2020
04:00PM

Dashboard UI/graphs updated

Broad-scale update across the entire dashboard to prepare for its launch onto the world wide web!
June 15, 2020
12:00AM

Dashboard graphs upgraded

Migrated dashboard graphs from Plotly to ECharts
June 04, 2020
08:06PM

Dashboard data source changed

Upgraded dashboard to use a database vs flat files. 3x reduction in load time
June 02, 2020
12:18PM

Dashboard UI upgraded

Overhauled dashboard user interface to use bs4dash
May 26, 2020
12:00AM

Variant tracking expanded

Began tracking variants in genes ORF1a and ORF1b
May 11, 2020
12:00AM

Variant tracking expanded

Began tracking variants in genes E, M, N, ORF3a, ORF7a, ORF8, and ORF10
April 27, 2020
12:00AM

Phylogenetic analysis added

Added tab containing viral genome evolutionary relationships
April 03, 2020
12:00AM

Automated QC pipeline created

Cleans up metadata fields such as age, collection date, gender, etc
April 02, 2020
10:36AM

First version of dashboard created

Created first version with shinydashboard. Data is ingested from flat files
March 31, 2020
12:00AM

Patient metadata tracking started

Began downloading patient metadata for all genomes
January 10, 2020
12:00AM

First data downloaded

Began downloading genomes from GISAID and subsequent variant calling



Loading...

Loading...